2026-11-01
$20M of new funding is targeting permitting licensing and inspections
1 funded company building into permitting licensing and inspections. The work in scope is what the Head of Regulatory Services owns today.
The funding
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.
US startup Origin raises $20M to build robots for construction →What it means
Capital arriving in a function is a reliable leading indicator. It does not mean the incumbents are wrong, and it does not mean these companies will succeed. It means that within the next few quarters the people who run this work will be asked what their function is doing about it, and the honest answer has to start with where that function actually stands.
So we built the assessment for it. Not a purchase decision, a structured set of questions to take to your own team.